MedTrace Logo

Validity and Reliability of the 6-minute Stepper Test in Patients With Peripheral Artery Disease

NCT07169045 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 24

Last updated 2026-02-03

No results posted yet for this study

Summary

Hemodynamic dysfunction and decreased blood flow to the extremities negatively affect patients' muscle oxygenation, balance, claudication pain, lower extremity muscle strength, and arterial stiffness. These negatively affect patients' exercise capacity. The six-minute stepper test (6 MST) is a simple, low-cost, and minimal space requirement assessment method used to evaluate functional exercise capacity and is known to be valid and reliable for various pulmonary and cardiovascular diseases. However, it is not known whether the 6 MST is valid and reliable in assessing functional exercise capacity in patients with PAD. It is known that muscle oxygen levels, balance levels, intermittent claudication, lower extremity muscle strength, and arterial stiffness have negative effects on exercise capacity. However, the extent to which these variables affect the 6 MST is unknown. The primary aim is to examine the validity and reliability of the 6 MST in patients with PAD. The secondary aim is to evaluate arterial stiffness, muscle oxygen levels, intermittent claudication, static and dynamic balance levels, lower extremity muscle strength, and examine their effects on the 6 MST.

Conditions

  • Peripheral Artery Disease (PAD)

Sponsors & Collaborators

  • Gazi University

    lead OTHER

Principal Investigators

  • Beyza BEKDEMİR · Gazi University

  • Nihan KATAYIFÇI · Gazi University

  • Abdullah ÖZER · Gazi University

  • Meral BOŞNAK GÜÇLÜ · Gazi University

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-09-24
Primary Completion
2026-07-24
Completion
2026-07-24

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07169045 on ClinicalTrials.gov